While others have demonstrated that tamoxifen resistant breast cancer lines LCC2 and LCC9 has elevated levels of UCA1, the tamoxifen resistance is caused by induction of p-AKT/m-TOR pathway[56]. The gene discussed is UCA1; the disease is breast cancer.